XM无法为美国居民提供服务。
I
I

Incyte

交易方向

交易者偏好

技术摘要

每小时

市场新闻

Incyte Corp <INCY.OQ> expected to post earnings of $1.11 a share - Earnings Preview

Incyte Corp expected to post earnings of $1.11 a share - Earnings Preview Incyte Corp INCY.OQ INCY.O is expected to show a rise in quarterly revenue when it reports results on October 29 for the period ending September 30 2024 The Wilmington Delaware-based company is expected to report a 17.1% increase in revenue to $1.076 billion from $919.03 million a year ago, according to the mean estimate from 18 analysts, based on LSEG data.
I

U.S. BXP, Medpace Holdings, Starbucks

U.S. RESEARCH ROUNDUP-BXP, Medpace Holdings, Starbucks Oct 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including BXP, Medpace Holdings and Starbucks, on Wednesday. HIGHLIGHTS * BXP Inc BXP.N : Piper Sandler raises to overweight from neutral * Danaher Corp DHR.N : TD Cowen raises target price to $315 from $310 * Medpace Holdings Inc MEDP.O : Jefferies cuts target price to $305 from $345 * Starbucks SBUX.O : Stifel cuts ta
I
M
P
S
Z
S
G
I

Incyte Announces Health Canada Approval Of Opzelura (Ruxolitinib) Cream For Treatment Of Atopic Dermatitis (AD) And Nonsegmental Vitiligo

BRIEF-Incyte Announces Health Canada Approval Of Opzelura (Ruxolitinib) Cream For Treatment Of Atopic Dermatitis (AD) And Nonsegmental Vitiligo Oct 16 (Reuters) - Incyte Corp INCY.O : INCYTE ANNOUNCES HEALTH CANADA APPROVAL OF OPZELURA (RUXOLITINIB) CREAM FOR TREATMENT OF ATOPIC DERMATITIS (AD) AND NONSEGMENTAL VITILIGO Source text for Eikon: ID:nC
I

Truist downgrades Incyte to "hold" on doubts of near-term prospects

BUZZ-Truist downgrades Incyte to "hold" on doubts of near-term prospects ** Truist Securities downgrades Incyte Corp INCY.O to "hold" from "buy", lowers PT to $74 from $83 ** Brokerage raises questions about whether co's pipeline in immunology and oncology will offset revenue losses from losing the 'exclusive' tag on its biggest-selling blood disor
I

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Bath & Body Works Inc BBWI.N +6.5% Intel Corp INTC.OQ +6.4% Oracle Corp ORCL.N +4.9% Incyte Corp INCY.OQ +4.3% Vistra Corp VST.N +4.2% Bottom Performers Percent Change Qorvo Inc QRVO.OQ -6.9% Skyworks Solutions Inc SWKS.OQ -5.9% Micron
I
I
M
Q
S
U

商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明